A lower benzodiazepine requirement can reflect the contribution of another depressant.
In the sequential pediatric study, alfentanil reduced the estimated remimazolam ED50 for loss of consciousness from about 0.340 to 0.212 mg/kg. The estimated ED95 also decreased. Recorded adverse-reaction frequency differed between the tested regimens.
The study included relatively healthy children aged three to twelve, without age-stratified analysis. These are combination-specific research estimates, not individual instructions or toxic thresholds. A lower amount of remimazolam does not mean that total pharmacological depression is necessarily lower.
Preserve the opioid exposure and the definition of consciousness loss when comparing estimates. An endpoint reached during induction does not measure later memory, analgesia or sustained ventilation. Case reconstruction needs actual doses and responses rather than applying a population effective-dose number to every child.
Source: PMC12405720, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: Pediatric Sedation Z-Scores Were Relative Burden Measures Rather Than Dose Equivalents.